Literature DB >> 33741048

A cluster randomized stepped-wedge trial to de-implement unnecessary post-operative antibiotics in children: the optimizing perioperative antibiotic in children (OPerAtiC) trial.

Sara Malone1,2, Virginia R McKay1, Christina Krucylak2, Byron J Powell1,3, Jingxia Liu4, Cindy Terrill2, Jacqueline M Saito5, Shawn J Rangel6, Jason G Newland7.   

Abstract

BACKGROUND: Antibiotic-resistant infections have become a public health crisis that is driven by the inappropriate use of antibiotics. In the USA, antibiotic stewardship programs (ASP) have been established and are required by regulatory agencies to help combat the problem of antibiotic resistance. Post-operative antibiotic use in surgical cases deemed low-risk for infection is an area with significant overuse of antibiotics in children. Consensus among leading public health organizations has led to guidelines eliminating post-operative antibiotics in low-risk surgeries. However, the best strategies to de-implement these inappropriate antibiotics in this setting are unknown. METHODS/<br> DESIGN: A 3-year stepped wedge cluster randomized trial will be conducted at nine US Children's Hospitals to assess the impact of two de-implementation strategies, order set change and facilitation training, on inappropriate post-operative antibiotic prescribing in low risk (i.e., clean and clean-contaminated) surgical cases. The facilitation training will amplify order set changes and will involve a 2-day workshop with antibiotic stewardship teams. This training will be led by an implementation scientist expert (VRM) and a pediatric infectious diseases physician with antibiotic stewardship expertise (JGN). The primary clinical outcome will be the percentage of surgical cases receiving unnecessary post-operative antibiotics. Secondary clinical outcomes will include the rate of surgical site infections and the rate of Clostridioides difficile infections, a common negative consequence of antibiotic use. Monthly semi-structured interviews at each hospital will assess the implementation process of the two strategies. The primary implementation outcome is penetration, which will be defined as the number of order sets changed or developed by each hospital during the study. Additional implementation outcomes will include the ASP team members' assessment of the acceptability, appropriateness, and feasibility of each strategy while they are being implemented. DISCUSSION: This study will provide important information on the impact of two potential strategies to de-implement unnecessary post-operative antibiotic use in children while assessing important clinical outcomes. As more unnecessary medical practices are identified, de-implementation strategies, including facilitation, need to be rigorously evaluated. Along with this study, other rigorously designed studies evaluating additional strategies are needed to further advance the burgeoning field of de-implementation. TRIAL REGISTRATION: NCT04366440. Registered April 28, 2020, https://clinicaltrials.gov/ct2/show/NCT04366440 .

Entities:  

Keywords:  Antibiotic stewardship; Cluster randomized stepped-wedge trial; De-implementation; Facilitation

Year:  2021        PMID: 33741048      PMCID: PMC7980649          DOI: 10.1186/s13012-021-01096-1

Source DB:  PubMed          Journal:  Implement Sci        ISSN: 1748-5908            Impact factor:   7.327


  49 in total

Review 1.  Managing and mitigating conflict in healthcare teams: an integrative review.

Authors:  Joan Almost; Angela C Wolff; Althea Stewart-Pyne; Loretta G McCormick; Diane Strachan; Christine D'Souza
Journal:  J Adv Nurs       Date:  2016-01-29       Impact factor: 3.187

2.  The qualitative content analysis process.

Authors:  Satu Elo; Helvi Kyngäs
Journal:  J Adv Nurs       Date:  2008-04       Impact factor: 3.187

Review 3.  The foundations of quality improvement science.

Authors:  Julie E Reed; Nicola Davey; Thomas Woodcock
Journal:  Future Hosp J       Date:  2016-10

4.  National Variability and Appropriateness of Surgical Antibiotic Prophylaxis in US Children's Hospitals.

Authors:  Thomas J Sandora; Monica Fung; Patrice Melvin; Dionne A Graham; Shawn J Rangel
Journal:  JAMA Pediatr       Date:  2016-06-01       Impact factor: 16.193

5.  Extended-Spectrum β-Lactamase-Producing and Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Children: Trends in the United States, 1999-2011.

Authors:  Latania K Logan; Nikolay P Braykov; Robert A Weinstein; Ramanan Laxminarayan
Journal:  J Pediatric Infect Dis Soc       Date:  2014-03-19       Impact factor: 3.164

6.  Appropriateness of Antibiotic Prescribing in United States Children's Hospitals: A National Point Prevalence Survey.

Authors:  Alison C Tribble; Brian R Lee; Kelly B Flett; Lori K Handy; Jeffrey S Gerber; Adam L Hersh; Matthew P Kronman; Cindy M Terrill; Mike Sharland; Jason G Newland
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

7.  Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.

Authors:  Latania K Logan; John P Renschler; Sumanth Gandra; Robert A Weinstein; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

8.  Unpacking the complexities of de-implementing inappropriate health interventions.

Authors:  Wynne E Norton; David A Chambers
Journal:  Implement Sci       Date:  2020-01-09       Impact factor: 7.327

Review 9.  Towards understanding the de-adoption of low-value clinical practices: a scoping review.

Authors:  Daniel J Niven; Kelly J Mrklas; Jessalyn K Holodinsky; Sharon E Straus; Brenda R Hemmelgarn; Lianne P Jeffs; Henry Thomas Stelfox
Journal:  BMC Med       Date:  2015-10-06       Impact factor: 8.775

10.  Psychometric assessment of three newly developed implementation outcome measures.

Authors:  Bryan J Weiner; Cara C Lewis; Cameo Stanick; Byron J Powell; Caitlin N Dorsey; Alecia S Clary; Marcella H Boynton; Heather Halko
Journal:  Implement Sci       Date:  2017-08-29       Impact factor: 7.327

View more
  1 in total

Review 1.  Stepped Wedge Cluster Randomized Trials: A Methodological Overview.

Authors:  Fan Li; Rui Wang
Journal:  World Neurosurg       Date:  2022-05       Impact factor: 2.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.